Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 497

1.

Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.

De La Fuente L, Bravo MJ, Barrio G, Parras F, Suárez M, Rodés A, Noguer I.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S410-5.

PMID:
14648456
2.

Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.

Mesquita F, Doneda D, Gandolfi D, Nemes MI, Andrade T, Bueno R, Piconez e Trigueiros D.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S382-5.

PMID:
14648452
3.
4.

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.

Hammett TM, Wu Z, Duc TT, Stephens D, Sullivan S, Liu W, Chen Y, Ngu D, Des Jarlais DC.

Addiction. 2008 Jan;103(1):137-45. Epub 2007 Nov 20. Review.

PMID:
18028519
5.

AIDS and the social relations of intravenous drug users.

Friedman SR, Des Jarlais DC, Sterk CE, Sotheran JL, Tross S, Woods J, Sufian M, Abdul-Quader A.

Milbank Q. 1990;68 Suppl 1:85-110. Erratum in: Milbank Q 1990;68(1):142.

PMID:
2381380
6.

HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.

de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T; Project Itínere Working Group.

J Clin Virol. 2006 Mar;35(3):244-9. Epub 2005 Sep 6.

PMID:
16143565
7.

Obstacles to the development of prevention and public health policies in Argentina.

Touzé G.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S372-5.

PMID:
14648450
8.

Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.

Inchaurraga S.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S366-71.

PMID:
14648449
9.
10.

Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.

Lavarello D, Lottero M, Chavero M, Toledo A, Espínola M, Gerlero S, Liborio M.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S353-7.

PMID:
14648446
11.

Drug use and HIV/AIDS in China.

Liu Z, Lian Z, Zhao C.

Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.

PMID:
16627308
12.

HIV/AIDS: Latin America & Caribbean. Puerto Rico: rich port, poor port.

Cohen J.

Science. 2006 Jul 28;313(5786):475-6. No abstract available.

PMID:
16873644
13.

Economic aspect of HIV/AIDS control and injecting drug use in Indonesia.

Siregar AY, Komarudin D, Leuwol B, Afriandi I, Djuhaeni H, Baltussen R.

Acta Med Indones. 2009 Jul;41 Suppl 1:70-4.

15.

[More than thirty years of illicit drugs in Spain: a bitter story with some messages for the future].

de la Fuente L, Brugal MT, Domingo-Salvany A, Bravo MJ, Neira-León M, Barrio G.

Rev Esp Salud Publica. 2006 Sep-Oct;80(5):505-20. Spanish.

16.

Rapid scale up of harm reduction in China.

Sullivan SG, Wu Z.

Int J Drug Policy. 2007 Mar;18(2):118-28. Epub 2007 Feb 14. Review.

PMID:
17689354
17.

The HIV/AIDS epidemic in China: history, current strategies and future challenges.

Wu Z, Rou K, Cui H.

AIDS Educ Prev. 2004 Jun;16(3 Suppl A):7-17. Review.

PMID:
15262561
18.
19.

Use of supervised injection facilities and injection risk behaviours among young drug injectors.

Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A; Itínere Project Group.

Addiction. 2009 Apr;104(4):614-9. doi: 10.1111/j.1360-0443.2008.02474.x. Epub 2009 Feb 10.

PMID:
19215603
20.

Injection drug use and HIV/AIDS transmission in China.

Chu TX, Levy JA.

Cell Res. 2005 Nov-Dec;15(11-12):865-9. Review.

Supplemental Content

Support Center